Vanguard Health Care (VGHAX) has a new manager, Rebecca Sykes. Well, maybe not so new. Sykes, who started with the fund as an analyst in 2007, joined Jean Hynes as comanager in 2023.
But at the start of 2025, Hynes stepped away from the fund — though she’ll stay on as chief executive of Wellington Management, the fund’s subadviser, a position she’s held since early 2021. “The change is part of a thoughtful, long-term succession plan,” a Vanguard spokesman said.
Health Care, which has $40.5 billion in assets, is the big kahuna of its category, so Sykes’s new role as sole manager — the third in the fund’s 40-year history — is noteworthy.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Challenges lie ahead. Although Health Care had the best 30-year annualized record of any U.S. stock mutual fund at the end of 2016, it has had uneven returns of late, and its 10-year annualized return now ranks below average.
Health Care Fund strategy
We’ll be watching the fund closely. Every new manager makes their mark on a fund, even if they’re well schooled in the previous manager’s ways. That said, Sykes says she will carry on the firm’s research-driven, team-focused and collaborative approach. And like Hynes, she will focus on undervalued companies of all sizes all over the world (non-U.S. stocks make up 27% of the fund’s portfolio) that are poised to play key roles in the future of medicine and healthcare.
“I believe innovation will continue to drive value over the long term,” says Sykes.
The fund typically balances hefty stakes in the managers’ highest-conviction stocks with smaller holdings in baskets of stocks to gain exposure to specific subsectors or themes. Top holding Eli Lilly (LLY), for instance, represents almost 10% of the fund’s assets.
But in 2024, with biotech shares languishing, the fund initiated new stakes in five biotech firms, including Avidity Biosciences and Crinetics Pharmaceuticals.
Help for healthcare stocks
Sykes says she’s excited about the future of healthcare. Clarity on the new administration’s policy on drug pricing, vaccines and government insurance programs could “help lift healthcare stocks,” she says. And new data for medicine to treat obesity, high cholesterol and lung cancer could “advance the standards of care and help reinvigorate the performance of biotech stocks.”
Note: This item first appeared in Kiplinger Personal Finance Magazine, a monthly, trustworthy source of advice and guidance. Subscribe to help you make more money and keep more of the money you make here.
Related content
-
You Could Save With 529 Plans for Homeschool: What to KnowSavings Accounts A new House plan might change how you save for your child's homeschool education. Find out how.
-
I'm 60 with a $4.2 million nest egg. Can I stop saving and start spending until I retire at 65?Should I continue contributing to my 401(k) or treat myself now?
-
My Professional Advice: When It Comes to Money, You Do YouThis is how embracing the 'letting others be' and 'learning to surrender' mindsets can improve your relationship with money.
-
Direct Indexing Expert Explains How It Can Be a Smarter Way to InvestDirect indexing provides a more efficient approach to investing that can boost after-tax returns, but is it right for you?
-
Stock Market Today: Stocks Brush Off Weak Jobs DataThe yields on the 2-year and 10-year Treasury notes fell sharply after a pair of weak economic reports.
-
What Does It Really Take to Retire Rich?With enough time and consistency, even an average income can lead to a wealthy retirement.
-
Smiley Faces in Serious Places: Emoji Use Pops Up in Legal Battles Over InheritancesEstate planning attorney notes how emojis are crossing over from casual conversation to litigation. What was once dismissed as 'just an emoji' is now carefully scrutinized.
-
When Downsizing, Does a Continuing Care Retirement Community Make Sense?The idea that you'll never have to move again may sound tempting, but how about the costs? A financial planner explores the pros and cons of this style of retirement living.
-
Fortune Favors the Gold: Expert Highlights a Little-Known Game-Changing Investing StrategyRather than only owning gold bullion itself and investing in gold mining companies, consider adding gold royalty companies to your gold investing strategy.
-
Stock Market Today: Rally Extends on Good-Enough ExpectationsFiscal policy still has markets' attention, but taxes rather than tariffs and deficits rather than inflation are participants' primary focus.
